Transcriptomics

Dataset Information

0

Gene expression analysis in control and HIF-2 alpha deficient murine lung endothelial cells under hypoxia


ABSTRACT: Journal : Blood. 2009 Jul 9;114(2):469-77. Epub 2009 May 13. Title : Endothelial deletion of hypoxia-inducible factor-2alpha (HIF-2alpha) alters vascular function and tumor angiogenesis. Authors : Skuli N, Liu L, Runge A, Wang T, Yuan L, Patel S, Iruela-Arispe L, Simon MC, Keith B. Abstract : Hypoxia-inducible factor-2alpha (HIF-2alpha) is highly expressed in embryonic vascular endothelial cells (ECs) and activates the expression of target genes whose products modulate vascular function and angiogenesis. In this report, we describe a genetic model designed to test the physiologic consequences of deleting HIF-2alpha in murine endothelial cells. Surprisingly, mice with HIF-2alpha-deficient ECs developed normally but displayed a variety of phenotypes, including increased vessel permeability, aberrant endothelial cell ultrastructure, and pulmonary hypertension. Moreover, these animals exhibited defective tumor angiogenesis associated with increased hypoxic stress and tumor cell apoptosis. Immortalized HIF-2alpha-deficient ECs displayed decreased adhesion to extracellular matrix proteins and expressed reduced levels of transcripts encoding fibronectin, integrins, endothelin B receptor, angiopoietin 2, and delta-like ligand 4 (Dll4). Together, these data identify unique cell-autonomous functions for HIF-2alpha in vascular endothelial cells. Keywords: Murine lung endothelial cell study

ORGANISM(S): Mus musculus

PROVIDER: GSE16067 | GEO | 2009/07/15

SECONDARY ACCESSION(S): PRJNA115489

REPOSITORIES: GEO

Dataset's files

Source:
Action DRS
Other
Items per page:
1 - 1 of 1

Similar Datasets

2009-07-15 | E-GEOD-16067 | biostudies-arrayexpress
2020-06-29 | MTBLS1764 | MetaboLights
2024-11-01 | GSE279434 | GEO
2017-08-04 | GSE102235 | GEO
2021-11-18 | GSE189071 | GEO
2013-11-05 | E-GEOD-43108 | biostudies-arrayexpress
2013-11-05 | GSE43108 | GEO
2022-05-08 | PXD026872 | Pride
2023-04-01 | GSE221264 | GEO
| 2242738 | ecrin-mdr-crc